The rapid development of China's bioindustry and life science research has led to a booming import demand for biomaterials and a growing variety of imported biomaterials. Facilitating the import of biomaterials has helped boost the bio-pharmaceutical industry and promote the supply-side structural reforms in the bioindustry The key link is the rapid development of biological industry and life science research in our country, the demand for biological materials import is more exuberant, the variety of imported biological materials is more numerous, the import of biological materials is facilitated, which will help the development of bio-pharmaceutical industry and promote the bio-industry supply side The key to structural reform.
For the new drug research and development enterprises, the time is the lifeline.Recently, the Shanghai Inspection and Quarantine Bureau "exempt from verification of the export of animal and plant quarantine certificates of the list (third edition)" was held in Zhangjiang CMC. With the aid of the New Deal of Biological Material Inspection and Quarantine, the research and development efficiency of Zhangjiang Bio-medical will be greatly enhanced. The qualified bio-medical materials will be able to complete the final quarantine examination and approval within 3 working days.
Facilitate the import of biological materials
Although bio-industry is a strategic emerging industry in our country, the bio-industry in our country is still in the initial stage although its development is rapid, meanwhile, the rapid development of bio-industry and life science research in our country requires more import of biomaterials and more import of biomaterials Many facilitate the import of biological materials, as to help the development of bio-pharmaceutical industry, promote the bio-industry supply-side structural reform key link.
Faced with the new form of development requirements, Shanghai Inspection and Quarantine Bureau in conjunction with AQSIQ, targeted the whole industry chain, the entire process of research, listen to scientific research, business opinions and suggestions, issued a new round of inspection and quarantine of bio-materials reform The measures include: Final approval of the final quarantine approval of 44 categories of imported biological materials in 6 major categories within 3 working days; Exemption of animal and plant quarantine approval of Class 9 imported biological materials.
Shanghai Branch to create a service
The relevant departments also took the initiative to dock Shanghai Free Trade Zone 3.0 and formulated the third edition of the "List of Animal and Plant Quarantine Certificates Exempted from Verification of Exported Countries or Areas." According to the introduction of SAIECIQ, Plant products, adjusted and increased to 18 kinds of animal and plant products These plants and animals to meet the additional requirements of the statement, can be regarded as 'low-risk animal and plant products', exempt from verification of foreign animal and plant quarantine certificates At the same time, the third edition of List, focusing on service life science research, service Shanghai Kechuangxinzhongxin.For example: model biology is a lot of life sciences research must introduce biological materials, exempt from verification of foreign animal and plant quarantine certificate will greatly simplify the mode of biological import procedures, convenience Scientific research carried out.
The relevant person in charge of Zhangjiang Administrative Committee said that the reform of the 'New Deal for Entry Inspection and Quarantine of Biological Materials for Entry into China' will be greatly intensified and will further boost the overall development of the bio-industry in Zhangjiang and the entire Shanghai. The release of the New Deal for Inspection and Quarantine of Biological Materials for Entry may be even more To meet the domestic biomedical enterprises and research institutes required for the development of biological materials supply will benefit Zhangjiang and Shanghai, more than 1,200 scientific research institutions, institutions, import and export enterprises and pharmaceutical R & D and manufacturing enterprises, to help the biopharmaceutical industry bigger and bigger, Better to seize a new round of development opportunities.
